Ibandronate Sodium Monohydrate
Cat. No.：YN270426
| 产品名称: | Ibandronate Sodium Monohydrate |
| CAS No.: | 138926-19-9 |
| Chemical Name: | P,P’-[1-hydroxy-3-(methylpentylamino)propylidene]bis-phosphonic acid, monosodium salt, monohydrate |
| Synonyms: | 伊班膦酸钠一水合物; BM-210955; RPR-102289A |
| 分子量: | 359.23 |
| 分子式: | C₉H₂₄NNaO₈P₂ |
| SMILES: | OC(P(O)(O)=O)(P(O)(O[Na])=O)CCN(C)CCCCC.O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Ibandronate 钠盐一水合物是高活性的含氮二磷酸盐，可用于骨质疏松。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Bell, N.H., and Johnson, R.H.Bisphosphonates in the treatment of osteoporosisEndocrine6(2),203-206(1997)
Hou, Y., Gu, K., Xu, C., et al.Dose-effectiveness relationships determining the efficacy of ibandronate for management of osteoporosis: A meta-analysisMedicine (Baltimore)94(26),e1007(2015)
Nancollas, G.H., Tang, R., Phipps, R.J., et al.Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatiteBone38(5),617-627(2006)
